Stryker Sells U.S. Spinal Implants Business, CFO To Retire; Sees FY Organic Sales Growth 8.0% – 9.0%
From Nasdaq: 2025-01-28 22:04:55
Stryker has agreed to sell its U.S. spinal implants business to Viscogliosi Brothers, LLC, creating a new company called VB Spine, LLC. VB Spine will be a strategic partner to Stryker with exclusive access to Mako Spine and Copilot for spine procedures. The transaction is expected to close in the first half of 2025. Additionally, Stryker announced the retirement of Glenn Boehnlein as CFO, with Preston Wells taking over the role on April 1, 2025. Stryker expects adjusted net earnings per share of $13.45 to $13.70 and organic net sales growth of 8.0% to 9.0% for 2025.
Read more at Nasdaq: Stryker Sells U.S. Spinal Implants Business, CFO To Retire; Sees FY Organic Sales Growth 8.0% – 9.0%